Y Kanakura
Overview
Explore the profile of Y Kanakura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
4062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akuta K, Kashiwagi H, Yujiri T, Nishiura N, Morikawa Y, Kato H, et al.
J Thromb Haemost
. 2018 Nov;
17(1):206-219.
PMID: 30388316
Essentials Acquired Glanzmann thrombasthenia (aGT) is generally caused by function-blocking antibodies (Abs). We demonstrated a unique aGT case due to marked reduction of αIIbβ3 with anti-αIIbβ3 Abs. The anti-αIIbβ3 Abs...
2.
Busch C, Koh S, Oie Y, Ichii M, Kanakura Y, Nishida K
Eye (Lond)
. 2017 Jul;
31(12):1745-1746.
PMID: 28707673
No abstract available.
3.
Maeda T, Hosen N, Fukushima K, Tsuboi A, Morimoto S, Matsui T, et al.
Blood Cancer J
. 2013 Aug;
3:e130.
PMID: 23912610
No abstract available.
4.
Tomiyama Y, Miyakawa Y, Okamoto S, Katsutani S, Kimura A, Okoshi Y, et al.
J Thromb Haemost
. 2012 Mar;
10(5):799-806.
PMID: 22409309
Background: Eltrombopag is an oral, non-peptide thrombopoietin receptor agonist that has shown efficacy and safety in chronic immune thrombocytopenia (ITP). However, ethnic differences in eltrombopag exposure have been reported: area...
5.
Sekine Y, Ikeda O, Mizushima A, Ueno Y, Muromoto R, Yoshimura A, et al.
Oncogene
. 2012 Jan;
31(40):4384-96.
PMID: 22231445
In chronic myeloid leukemia (CML), the BCR-ABL fusion oncoprotein activates multiple pathways involved in cell survival, growth promotion and disease progression. In this report, we show that the signal-transducing adaptor...
6.
Satoh Y, Matsumura I, Tanaka H, Harada H, Harada Y, Matsui K, et al.
Leukemia
. 2011 Aug;
26(2):303-11.
PMID: 21836608
Loss-of-function mutations of RUNX1 have been found in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Although several reports have suggested roles for RUNX1 as a tumor suppressor, its precise...
7.
Kitayama H, Kanakura Y, Furitsu T, Ikeda H, Hirota S, Sugahara H, et al.
Int J Oncol
. 2011 May;
2(2):213-9.
PMID: 21573539
We have investigated the effects of c-kit ligand (stem cell factor [SCF]) and interleukin-3 (IL-3) on proliferation and differentiation of a human chronic myelogenous leukemia cell line, KU812F, which can...
8.
Kamae T, Kiyomizu K, Nakazawa T, Tadokoro S, Kashiwagi H, Honda S, et al.
J Thromb Haemost
. 2011 Feb;
9(5):1040-8.
PMID: 21342433
Background: Thromboxane A(2) receptor (TXA(2)R) abnormality appears to dominantly disturb platelet function. Objectives: To reveal a molecular genetic defect in a patient with TXA(2)R abnormality and investigate the mechanism for...
9.
Akiyama M, Kashiwagi H, Todo K, Moroi M, Berndt M, Kojima H, et al.
J Thromb Haemost
. 2009 Jun;
7(8):1373-83.
PMID: 19522742
Background: Glycoprotein (GP)VI deficiency is a rare platelet disorder with a mild bleeding tendency. However, its pathophysiology remains unclear. Objectives: We characterized a novel GPVI-deficient patient with immune thrombocytopenic purpura...
10.
Yamauchi A, Ikeda J, Nakamichi I, Kohara M, Fukuhara S, Hino M, et al.
Histopathology
. 2008 Apr;
52(6):731-7.
PMID: 18397280
Aims: Diffuse large B-cell lymphoma (DLBCL) usually proliferates effacing lymph follicles. In occasional cases, tumour cells show an interfollicular pattern of proliferation preserving lymph follicles. The aim was to analyse...